These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38170031)

  • 1. Artificial Intelligence-Based Diagnostic Support System for Functional Dyspepsia Based on Brain Activity and Food Preference.
    Katsumata R; Hosokawa T; Kamada T
    Cureus; 2023 Dec; 15(12):e49877. PubMed ID: 38170031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia.
    Katsumata R; Hosokawa T; Manabe N; Mori H; Wani K; Ishii K; Tanikawa T; Urata N; Ayaki M; Nishino K; Murao T; Suehiro M; Fujita M; Kawanaka M; Haruma K; Kawamoto H; Takao T; Kamada T
    J Gastroenterol; 2023 Dec; 58(12):1178-1187. PubMed ID: 37572136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association among Disorders of Gut-Brain Interaction (DGBI) and Fibromyalgia: A Prospective Study.
    Settembre C; D'Antonio E; Moscato P; Loi G; Santonicola A; Iovino P
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI.
    Coitinho Y; Naude C; Marchese SH; Evans S; Barber E; Parigi E; Cheah S; Palsson O; Sperber AD; Tack J; Drossman D; Mikocka-Walus A; Taft T
    Neurogastroenterol Motil; 2024 Oct; ():e14936. PubMed ID: 39370619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.
    Simons J; Shajee U; Palsson O; Simren M; Sperber AD; Törnblom H; Whitehead W; Aziz I
    United European Gastroenterol J; 2022 Sep; 10(7):736-744. PubMed ID: 35781806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome.
    Marasco G; Maida M; Cremon C; Barbaro MR; Stanghellini V; Barbara G
    Aliment Pharmacol Ther; 2023 Jul; 58(1):6-15. PubMed ID: 37038318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Fukudo S; Nakaya K; Muratsubaki T; Nakaya N; Hozawa A; Bangdiwala SI; Palsson OS; Sperber AD; Kanazawa M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14581. PubMed ID: 37093785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Food Preferences in Patients with Gastrointestinal Disorders.
    Katsumata R; Kaburagi T; Hosokawa T; Manabe N; Ishii M; Ishii K; Tanikawa T; Urata N; Ayaki M; Nishino K; Murao T; Suehiro M; Fujita M; Kawanaka M; Haruma K; Kawamoto H; Takao T; Kamada T
    Intern Med; 2024 Apr; ():. PubMed ID: 38599865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology and impact of disorders of gut-brain interaction in Canada: Results from the Rome Foundation Global Epidemiologic Study.
    Rodrigues DM; Poitras P; Day AG; Sperber AD; Palsson O; Bangdiwala SI; Vanner SJ
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14585. PubMed ID: 36989173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.
    Talley NJ; Holtmann G; Walker MM; Burns G; Potter M; Shah A; Jones M; Koloski NA; Keely S
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00064. PubMed ID: 31356481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.
    Flores-Arriaga J; Aso MC; Izagirre A; Sperber AD; Palsson OS; Bangdiwala SI; Lanas Á; Bujanda L; Lobo B; Alonso-Cotoner C; Sánchez-Pla Á; Santos J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14582. PubMed ID: 37010843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of disorders of Gut-Brain interaction in Israel: Results from the Rome Foundation global epidemiology study.
    Sperber AD; Freud T; Abu-Freha N; Shibli F; Brun R; Bangdiwala SI; Palsson OS; Dickman R
    Neurogastroenterol Motil; 2022 Aug; 34(8):e14323. PubMed ID: 35072332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    Futagami S; Kessoku T; Kasai Y; Higurashi T; Nakajima A; Agawa S; Yamawaki H; Nakamura K; Habiro M; Kawawa R; Ueki N; Higashida S; Watanabe Y; Yamato H; Yamamoto T; Takasaki Y; Ito K; Hojo M; Isayama H; Motoda N; Ohashi R; Siah KTH; Ng CK; Gwee KA
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1778-1786. PubMed ID: 37278449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of disorders of gut-brain interaction in Belgium and differences between two language groups: Results from the Rome foundation global epidemiology study.
    Broeders B; Devolder E; Jones M; Simrén M; Bangdiwala SI; Sperber AD; Palsson OS; Tack J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14588. PubMed ID: 37018388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the epidemiology of disorders of gut-brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study.
    Schmulson MJ; Puentes-Leal GA; Bustos-Fernández L; Francisconi C; Hani A; López-Colombo A; Palsson OS; Bangdiwala SI; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14569. PubMed ID: 36989176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
    Andreev DN; Bordin DS; Vyuchnova ES; Lebedeva EG; Dicheva DT; Umyarova RM; Maev IV
    Ter Arkh; 2022 Oct; 94(9):1099-1108. PubMed ID: 36286762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.